FGFR Gene Amplification

general

A molecular genetic abnormality indicating the presence of multiple copies of the FGFR3 gene.

Centers

Active Trials

$13.7B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
FGFR2 Gene Amplification	65	15
FGFR1 Gene Amplification	64	—

Top Centers for FGFR Gene Amplification(66)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	75.9
2	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	53.4
4	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	53.4
5	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
6	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	53.4
7	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	2	—	53.4
8	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	53.4
9	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	$754M	—
10	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive		—	$738M	—
11	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		—	$737M	—
12	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	$604M	—
13	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		1	$534M	—
14	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	$517M	—
15	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		—	$509M	—
16	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	$507M	—
17	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive		—	$505M	—
18	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive		—	$484M	—
19	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	$454M	—
20	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		1	$452M	—
21	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive		—	$438M	—
22	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	$375M	—
23	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive		—	$370M	—
24	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive		—	$347M	—
25	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive		—	$332M	—
26	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	$319M	—
27	Moffitt Cancer CenterTampa, FL NCI Comprehensive		1	$296M	—
28	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	$276M	—
29	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	$262M	—
30	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive		—	$246M	—
31	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive		—	$227M	—
32	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive		—	$223M	—
33	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	$222M	—
34	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive		—	$216M	—
35	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical		—	$194M	—
36	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		1	$186M	—
37	Medical College of Wisconsin Cancer CenterMilwaukee, WI		—	$181M	—
38	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive		—	$163M	—
39	Cleveland Clinic Cancer CenterCleveland, OH		1	$150M	—
40	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive		—	$146M	—
41	Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive		—	$146M	—
42	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive		—	$144M	—
43	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	$143M	—
44	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive		—	$136M	—
45	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive		—	$130M	—
46	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	$116M	—
47	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive		—	$110M	—
48	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	$106M	—
49	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		1	$103M	—
50	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX		—	$83M	—
51	Cancer Center at IllinoisUrbana, IL		—	$81M	—
52	Penn State Cancer InstituteHershey, PA		—	$73M	—
53	The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory		—	$72M	—
54	University of Cincinnati Cancer CenterCincinnati, OH		1	$71M	—
55	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		1	$59M	—
56	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ		1	$58M	—
57	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	$53M	—
58	The University of Vermont Cancer CenterBurlington, VT		—	$43M	—
59	Northwell Health Cancer InstituteNew York, NY		—	$18M	—
60	Upstate Cancer CenterSyracuse, NY		—	$15M	—
61	University of Texas Medical Branch Cancer CenterGalveston, TX		—	$15M	—
62	Loma Linda University Cancer CenterLoma Linda, CA		—	$10M	—
63	Louisiana Cancer Research CenterNew Orleans, LA		—	—	—
64	Princess Margaret Cancer CentreToronto, ON		1	—	—
65	Tampa General Hospital Cancer InstituteTampa, FL		1	—	—
66	Murtha Cancer Center at Walter Reed BethesdaBethesda, MD		—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →